Clinical Trials Browser

Phase 2 × Trabectedin × Sarcoma × Clear all

NCT04305548 2026-03-27

ISG-MCS

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

NCT04383119 2026-03-25

ISG-ARTICLE

Phase 2 Recruiting

Sarcoma

NCT01303094 2026-03-16

T-DIS

Phase 2 Completed

Sarcoma

NCT04794127 2026-02-18

TRABEPIO

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

NCT04076579 2025-08-29

Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma

Phase 2 Completed

29 enrolled 13 charts

Sarcoma

NCT06524583 2025-03-30

L-UteCIN

Phase 2 Recruiting

Leiomyosarcoma Uterus

NCT03886311 2025-02-24

TNT

Phase 2 Recruiting

Sarcoma

NCT04535271 2025-02-24

TAGGED

Phase 2 Recruiting

Leiomyosarcoma

NCT05131386 2023-03-27

SYNERGIAS

Phase 2 Unknown

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02359474 2023-02-28

HyperTET

Phase 2 Unknown

Sarcoma

NCT03590210 2022-11-08

NiTraSarc

Phase 2 Completed

Sarcoma

NCT02247544 2021-11-01

TRAVELL

Phase 2 Completed

Leiomyosarcoma, Liposarcoma, Ichthyosis, X-Linked

NCT02993705 2021-08-25

MITO 26

Phase 2 Completed

Carcinosarcoma

NCT03397186 2019-09-10

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Phase 2 Withdrawn

Sarcoma, Liposarcoma, Myxoid

NCT00070109 2018-09-14

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Phase 2 Completed

50 enrolled 18 charts

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

NCT00379145 2017-12-12

Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus

Phase 2 Completed

20 enrolled 7 charts

Sarcoma

NCT02249702 2017-12-06

TAUL

Phase 2 Completed

Leiomyosarcoma

NCT01104298 2015-10-27

Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

Phase 2 Terminated

Sarcoma, Ichthyosis, X-Linked

NCT00060944 2014-09-08

A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer

Phase 2 Completed

271 enrolled 13 charts

Leiomyosarcoma, Liposarcoma, Neoplasm Metastasis, Neoplasms

NCT00579501 2014-05-07

Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma

Phase 2 Completed

29 enrolled 7 charts

Liposarcoma, Liposarcoma, Myxoid

NCT00786838 2014-04-11

A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram

Phase 2 Completed

76 enrolled 17 charts

BreastGynecologicSarcoma

Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Sarcoma

NCT00017030 2013-06-26

Ecteinascidin 743 in Treating Patients With Unresectable Advanced or Metastatic Soft Tissue Sarcoma

Phase 2 Completed

Sarcoma

NCT00005625 2013-06-19

Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic Osteosarcoma

Phase 2 Completed

Sarcoma, Osteosarcoma

NCT00003939 2012-09-24

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2 Completed

CNSGastrointestinalGynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Gastrointestinal Stromal Tumors, Histiocytoma, Malignant Fibrous